NASDAQ:GLSI | Cash Flow Statement | Greenwich LifeSciences, Inc.

Complete source-backed cash-flow history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$3.95M
2026-03-31-$5.66M-$4.7M$9.03M
2025-12-31-$9.15M-$3.17M$5.55M
2025-09-30-$4.15M
2025-06-30-$3.75M
2025-03-31-$2.74M-$1.83M$492,423.00
2024-12-31-$9.67M-$1.85M$121,829.00
2024-09-30-$2.67M
2024-06-30-$2.61M
2024-03-31-$2.47M-$1.78M$299,116.00
2023-12-31-$2.75M-$2.15M
2023-09-30-$2.39M
2023-06-30-$1.63M
2023-03-31-$2.12M-$1.56M
2022-12-31-$2.79M-$2.17M$0.00$0.00
2022-09-30-$2.32M
2022-06-30-$746,073.00
2022-03-31-$1.97M-$1.95M$5.51M-$5.51M
2021-12-31-$2.36M-$2.26M$562,596.00
2021-09-30-$863,118.00
2021-06-30-$749,745.00
2021-03-31-$597,008.00-$528,270.00$2.27M
2020-12-31-$1.15M$23.6M
2020-09-30-$256,865.00
2020-06-30-$210,430.00
2020-03-31-$244,641.00
2019-12-31-$336,536.00-$214,167.00
2019-09-30-$336,013.00
2019-06-30-$2.6M
2019-03-31-$148,731.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$19.36M-$9.91M$12M
2024-12-31-$17.41M-$7.27M$4.37M
2023-12-31-$8.89M-$6.48M
2022-12-31-$7.83M-$6.2M$7.54M-$7.54M
2021-12-31-$4.57M-$4.29M$2.84M
2020-12-31-$1.86M-$1.15M$29.81M
2019-12-31-$3.43M-$293,267.00$215,000.00